BIG PHARMA WATCH: BIG PHARMA’S JANUARY PRICE HIKES CLIMB TO 588
Jan 7, 2022
Brand Name Drug Companies’ Business-as-Usual Approach to Price Increases… Read More
© 2026 CSRXP- All Rights Reserved
Blog Posts
DOSE OF REALITY: BIG PHARMA’S YEAR OF BAD BEHAVIOR — PART I
Dec 28, 2021
Part I: Price-Gouging An Unproven Treatment, Setting Out-of-Control Launch… Read More
DOSE OF REALITY: BIG PHARMA’S YEAR OF BAD BEHAVIOR — PART II
Dec 28, 2021
Part II: Pushing Debunked Innovation Rhetoric to Oppose Rx Solutions Despite… Read More
DOSE OF REALITY: BIG PHARMA’S YEAR OF BAD BEHAVIOR — PART III
Dec 28, 2021
Part III: Big Pharma Maintains Price-Hiking, Patent-Gaming Business-As-Usual… Read More
DOSE OF REALITY: OVERSIGHT REPORT EXPOSES BIG PHARMA’S EGREGIOUS PRICING & ANTI-COMPETITIVE TACTICS — DEBUNKS INNOVATION RHETORIC
Dec 12, 2021
Investigation Finds Big Pharma Hiked Prices More Than 250 Times On Just 12 Top… Read More
SECOND OPINION: BIG PHARMA DOUBLES DOWN ON BLAME GAME STRATEGY AMID UNPRECEDENTED MOMENTUM TO LOWER RX PRICES
Dec 3, 2021
New PhRMA Ad Campaign Aims to Dodge Accountability, Push Pharma-Backed Rebate… Read More
BIG PHARMA WATCH: UNJUSTIFIED PRICE HIKES ON JUST SEVEN BRAND NAME DRUGS COST U.S. $1.6 BILLION IN 2020
Nov 16, 2021
New Analysis Underscores How Big Pharma’s Price Increases Cost The American… Read More
BIG PHARMA EARNINGS WATCH: ASTRAZENECA
Nov 15, 2021
AstraZeneca’s Q3 Earnings Report Shows Pandemic Price Hikes Profitable for… Read More
BIG PHARMA EARNINGS WATCH: SANOFI, ABBVIE, PFIZER & AMGEN
Nov 9, 2021
New Round of Q3 Earnings Reports Continue to Show Big Pharma Profits Buoyed By… Read More
BIG PHARMA WATCH: BIG PHARMA SPENDS $263M ON LOBBYING, CAMPAIGN DONATIONS FIGHTING SOLUTIONS TO LOWER RX PRICES
Nov 4, 2021
New Analysis Highlights How Big Pharma Uses Limitless Resources… Read More
BIG PHARMA EARNINGS WATCH: NOVARTIS, MERCK, GLAXO SMITH KLINE, BRISTOL-MYERS SQUIBB
Nov 1, 2021
New Q3 Earnings Reports Underscore How Price Hikes, Anti-Competitive Tactics… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON, ROCHE
Oct 22, 2021
First Round of Q3 Earnings Reports Show Big Pharma Companies Raking in Big… Read More